304 related articles for article (PubMed ID: 9216695)
21. Expression of beta-catenin and E-cadherin in the adenoma-carcinoma sequence of the stomach.
Kim HS; Hong EK; Park SY; Kim WH; Lee HS
Anticancer Res; 2003; 23(3C):2863-8. PubMed ID: 12926124
[TBL] [Abstract][Full Text] [Related]
22. Relation of E-cadherin and beta-catenin expression to pit pattern in colorectal cancer.
Kojima M; Shiokawa A; Ohike N; Tamegai Y; Kato H; Morohoshi T
Oncol Rep; 2004 Sep; 12(3):533-8. PubMed ID: 15289833
[TBL] [Abstract][Full Text] [Related]
23. Beta- and gamma-catenin expression in thyroid carcinomas.
Cerrato A; Fulciniti F; Avallone A; Benincasa G; Palombini L; Grieco M
J Pathol; 1998 Jul; 185(3):267-72. PubMed ID: 9771480
[TBL] [Abstract][Full Text] [Related]
24. Expression of E-cadherin and catenins in invasive mammary carcinomas.
Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
[TBL] [Abstract][Full Text] [Related]
25. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity.
Bagutti C; Speight PM; Watt FM
J Pathol; 1998 Sep; 186(1):8-16. PubMed ID: 9875134
[TBL] [Abstract][Full Text] [Related]
26. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
[TBL] [Abstract][Full Text] [Related]
27. Expression of classic cadherins type I in urothelial neoplastic progression.
Rieger-Christ KM; Cain JW; Braasch JW; Dugan JM; Silverman ML; Bouyounes B; Libertino JA; Summerhayes IC
Hum Pathol; 2001 Jan; 32(1):18-23. PubMed ID: 11172290
[TBL] [Abstract][Full Text] [Related]
28. Expression of E-cadherin and beta-catenin in the adenoma-carcinoma sequence of ampulla of Vater cancer.
Park S; Kim SW; Lee BL; Jung EJ; Kim WH
Hepatogastroenterology; 2006; 53(67):28-32. PubMed ID: 16506371
[TBL] [Abstract][Full Text] [Related]
29. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
[TBL] [Abstract][Full Text] [Related]
30. Mucoepidermoid carcinoma of the thyroid: a tumour histotype characterised by P-cadherin neoexpression and marked abnormalities of E-cadherin/catenins complex.
Rocha AS; Soares P; Machado JC; Máximo V; Fonseca E; Franssila K; Sobrinho-Simões M
Virchows Arch; 2002 May; 440(5):498-504. PubMed ID: 12021924
[TBL] [Abstract][Full Text] [Related]
31. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
[TBL] [Abstract][Full Text] [Related]
32. E-cadherin and catenins: molecules with versatile roles in normal and neoplastic epithelial cell biology.
El-Bahrawy MA; Pignatelli M
Microsc Res Tech; 1998 Nov; 43(3):224-32. PubMed ID: 9840800
[TBL] [Abstract][Full Text] [Related]
33. N-cadherin-catenin interaction: necessary component of cardiac cell compartmentalization during early vertebrate heart development.
Linask KK; Knudsen KA; Gui YH
Dev Biol; 1997 May; 185(2):148-64. PubMed ID: 9187080
[TBL] [Abstract][Full Text] [Related]
34. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines.
Noda M; Tatsumi Y; Tomizawa M; Takama T; Mitsufuji S; Sugihara H; Kashima K; Hattori T
J Gastroenterol; 2002; 37(11):896-904. PubMed ID: 12483244
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors.
Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F
Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
[TBL] [Abstract][Full Text] [Related]
37. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
[TBL] [Abstract][Full Text] [Related]
38. Cadherin-catenin expression in primary colorectal cancer: a survival analysis.
Hugh TJ; Dillon SA; Taylor BA; Pignatelli M; Poston GJ; Kinsella AR
Br J Cancer; 1999 Jun; 80(7):1046-51. PubMed ID: 10362114
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
[TBL] [Abstract][Full Text] [Related]
40. Re-expression of E-cadherin, alpha-catenin and beta-catenin, but not of gamma-catenin, in metastatic tissue from breast cancer patients [seecomments].
Bukholm IK; Nesland JM; Børresen-Dale AL
J Pathol; 2000 Jan; 190(1):15-9. PubMed ID: 10640987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
